Results 51 to 60 of about 211,753 (383)

Systematic review of the safety of medication use in inpatient, outpatient and primary care settings in the Gulf Cooperation Council countries [PDF]

, 2018
Background Errors in medication use are a patient safety concern globally, with different regions reporting differing error rates, causes of errors and proposed solutions.
Abu Yassin, Abushaiqa, Ackroyd-Stolarz, Al Anany, Al Anazi, Al Hamid, Al Khaja, Al Khaja, Al Khaja, Al Khaja, Al Khaja, Al Odhayani, Al Rahbi, Al Shahaibi, Al-Arifi, Al-Arifi, Al-Dhawailie, Al-Ghamdi, Al-Hussein, Al-Jazairi, Al-Jeraisy, Al-Khani, Al-Olah, Al-Omar, Al-Rashdi, Al-Rowibah, Al-Tajir, Alakhali, Alanazi, Albarrak, Alghamdy, Aljadhey, Aljadhey, Aljadhey, Aljamal, Allan, Almazrou, Alshaikh, Alsulaimi, Altebenaui, American Geriatrics Society Beers Criteria Update Expert Panel, Arabi, Aseeri, ASHP, Bates, Bryony Dean Franklin, Cohen, Dean, Dean, Dean, Dean, Dibbi, Elnour, Ferner, Fick, Flynn, Flynn, Gandhi, Ghaleb, Ghaleb, Hemida, Hepler, Hisham Saad Aljadhey, Hooper, Insley, Irshaid, Jamilah Alsaidan, Jane Portlock, Jha, Jha, Kaushal, Kheir, Khoja, Landis, Lisby, Mahmoud, McLeod, McPhillips, Mendonca, Miller, Mitwally, Morimoto, Morimoto, Nada Atef Shebl, Naranjo, Nebeker, Neville, Rancourt, Rashed, Rashed, Rehmani, Sadat-Ali, Shaughnessy, Sonallah, WHO, World Bank   +95 more
core   +3 more sources

DEVELOPING A CHALLENGES LANDSCAPE RELATING TO DRUG SAFETY, PROVISION, AND DISTRIBUTION IN RESOURCE-LIMITED SETTINGS FOR THE CASE OF HIV/AIDS

South African Journal of Industrial Engineering, 2018
Since 2010, pharmaceutical organisations have begun to provide drug patents in sub-Saharan Africa through the UN Medicine Patent Pool. This initiative allows any pharmaceutical manufacturer to access these patents and manufacture the drugs, thereby ...
Huysamen, Biance, de Kock, Imke H., Bam, Louzanne   +2 more
doaj   +1 more source

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors [PDF]

Vojnosanitetski Pregled, 2011
Introduction. Angiotensin-converting enzyme inhibitors are leading cause of drug-induced angioedema, with incidence of 0.1 to 0.2%. The angioedema is not of immune nature; in predisposed individuals it is caused by accumulation of vasoactive mediators
Janković Slobodan M., Stefanović Srđan M.   +1 more
doaj   +1 more source

An annotated corpus with nanomedicine and pharmacokinetic parameters [PDF]

, 2017
A vast amount of data on nanomedicines is being generated and published, and natural language processing (NLP) approaches can automate the extraction of unstructured text-based data. Annotated corpora are a key resource for NLP and information extraction
Jimenez, Ivan, Lewinski, Nastassja, McInnes, Bridget   +2 more
core   +2 more sources

Perception of Nigerian medical students on adverse drug reaction reporting

Journal of Advanced Pharmaceutical Technology & Research, 2015
Spontaneous reporting (SPR) and intensive monitoring are the conventional systems used for detecting, recording, and reporting adverse drug reactions (ADRs).
A. Abubakar, Bashir A. Z. Chedi, K. Mohammed, M. Haque   +3 more
semanticscholar   +1 more source

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database

Frontiers in Pharmacology, 2022
Triazole antifungal drugs (TAD) are widely used to treat invasive fungal infections due to their broad antifungal spectrum and low toxicity. Despite their preference in the clinic, multiple Adverse Events (AE) are still reported each year.
Jianxing Zhou, Zipeng Wei, Baohua Xu, Maobai Liu, Ruichao Xu, Xuemei Wu   +5 more
semanticscholar   +1 more source

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

Cadernos de Saúde Pública, 2021
: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events.
Nayara Aparecida de Oliveira Silva, Ana Laura de Sene Amâncio Zara, Albert Figueras, Daniela Oliveira de Melo   +3 more
doaj   +1 more source

Safety profile of oxcarbazepine: results from a prescription-event monitoring study [PDF]

, 2010
Purpose: To monitor safety of oxcarbazepine, prescribed in primary care in England, using prescription-event monitoring (PEM). Methods: Postmarketing surveillance using observational cohort technique of PEM.
Buggy, Y., Fogg, Carole, Layton, D., Shakir, S.   +3 more
core   +1 more source

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system [PDF]

Frontiers in Pharmacology
IntroductionDrug trials in neonates are scarce, and the neonates may consequently be at risk of adverse drug reactions (ADRs). Spontaneous ADR reporting is an important tool for expanding the knowledge on drug safety in neonates. This study explores the quality of current neonatal ADR reports and the ADR reports of the most common drugs used in ...
Pernille Kähler Byskov, Christoffer Storm Baden, Jon Trærup Andersen, Jon Trærup Andersen, Espen Jimenez-Solem, Espen Jimenez-Solem, Ramus Huan Olsen, Ramus Huan Olsen, Christina Gade, Christina Gade, Ulrik Lausten-Thomsen   +10 more
openaire   +4 more sources

Never events in UK general practice: a survey of the views of general practitioners on their frequency and acceptability as a safety improvement approach [PDF]

, 2019
Background: Never events (NEs) are serious preventable patient safety incidents and are a component of formal quality and safety improvement (Q&SI) policies in the United Kingdom and elsewhere.
Alam, Rahul, Bowie, Paul, Campbell, Stephen, Cheraghi-Sohi, Sudeh, de Wet, Carl, Esmail, Aneez, Stocks, Susan J.   +6 more
core   +2 more sources